NON-SMALL CELL LUNG CANCER
Clinical trials for NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills plus immunotherapy: new hope for lung cancer?
Disease control Not yet recruitingThis study tests whether a fecal microbiota transplant (FMT) combined with the drug tislelizumab can help people with advanced non-small cell lung cancer whose disease got worse after standard immunotherapy. The goal is to see if changing gut bacteria can restore the immune syste…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Apr 28, 2026 23:52 UTC
-
New drug cocktail aims to outsmart lung cancer resistance
Disease control Not yet recruitingThis study tests a new drug (ANS014004) combined with a standard targeted therapy (EGFR-TKI) in people with advanced EGFR-mutated non-small cell lung cancer. The goal is to find a safe dose and see if the combination can shrink tumors or stop them from growing, especially when th…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Apr 28, 2026 23:49 UTC
-
New hope for tough cancers: experimental drug ITC-6146RO enters human testing
Disease control Not yet recruitingThis early-phase study tests a new drug called ITC-6146RO in about 100 adults with advanced or metastatic cancers (prostate, lung, breast, or other solid tumors) that have not responded to standard therapies. The goal is to find a safe dose and check for early signs of tumor shri…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Apr 28, 2026 23:49 UTC
-
New hope for lung cancer patients whose disease returned after targeted therapy
Disease control Not yet recruitingThis study is for people with a specific type of lung cancer (EGFR-mutant) that has spread to other parts of the body after they finished a targeted therapy called osimertinib. The goal is to see if adding chemotherapy to osimertinib can help control the cancer for longer. About …
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Can acupuncture boost lung cancer treatment? new trial aims to find out
Symptom relief Not yet recruitingThis study looks at whether adding electro-acupuncture to usual immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. About 424 participants will receive either real or fake acupuncture during their first few treatment cycles. The main goal is t…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC
-
New study tests cheaper, safer CT scans for lung surgery planning
Knowledge-focused Not yet recruitingThis study compares 3D models made from CT scans without contrast dye to standard 2D contrast CT scans for planning minimally invasive lung surgery. Researchers want to see if the 3D approach is just as accurate at showing blood vessels, airways, and tumor location. About 50 adul…
Matched conditions: NON-SMALL CELL LUNG CANCER
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:51 UTC
-
Blood test may predict who benefits from lung cancer combo therapy
Knowledge-focused Not yet recruitingThis study looks at whether changes in certain immune cells in the blood can help predict how well people with advanced lung cancer respond to a combination of chemotherapy and immunotherapy. Researchers will collect blood samples from 80 participants before and after two treatme…
Matched conditions: NON-SMALL CELL LUNG CANCER
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:51 UTC
-
Electric fields before lung surgery: a new hope?
Knowledge-focused Not yet recruitingThis early study tests a non-invasive device that delivers low-intensity electric fields (TTFields) to people with stage I to IIIA non-small cell lung cancer before they have surgery. The main goal is to see how these fields affect certain genes linked to DNA repair. About 18 adu…
Matched conditions: NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:50 UTC